MeSH tree: C04.557.450.565.575
Pioneering work in comparative oncology continues at UC Davis with the launch of a Canine Tumor Genome Atlas, the first genomic data bank of its kind outside of one developed by the National Cancer Institute. Eventually it ...
Aug 8, 2023
0
61
A team of scientists led by Nanyang Technological University, Singapore (NTU Singapore) has found that an existing cancer drug could be repurposed to target a subset of cancers that currently lack targeted treatment options ...
Jul 10, 2023
0
40
New research has identified a potential therapeutic target and developed a unique delivery system to treat osteosarcoma, a bone cancer that primarily affects children and adolescents.
Apr 27, 2023
0
43
Peter Mac researchers have developed a new approach to chimeric antigen receptor (CAR) T-cell therapy which has proven effective in fighting solid cancer tumors.
Apr 7, 2023
0
142
A new editorial paper titled "Unlocking the potential of molecular-driven stratification for osteosarcoma treatment and prognosis" has been published in Oncotarget.
Mar 20, 2023
0
30
Tumor cells won't show their true selves in a petri dish, isolated from other cells.
Mar 20, 2023
0
42
A study published in the Journal of Orthopaedic Research has identified a bone matrix protein called Secreted phosphoprotein 24 kD (Spp24) that may help to treat osteosarcoma, the most common type of bone cancer.
Mar 8, 2023
0
34
Scientists at Cold Spring Harbor Laboratory (CSHL) have discovered a new drug target for Ewing sarcoma, a rare kind of cancer usually diagnosed in children and young adults. Their experiments show that the cells causing this ...
Jan 19, 2023
0
83
A new research paper was published in Genes & Cancer on December 14, 2022, entitled, "Slit2 signaling stimulates Ewing sarcoma growth."
Jan 16, 2023
0
31
Two men buried long ago in a medieval graveyard in Co. Donegal had a genetic condition called multiple osteochondromas, which causes benign bone tumors. One of the disease mutations is a new discovery, so this is the first ...
Dec 5, 2022
0
56
